ATG7 and neoplasm: Mice treated with TRI-03 presented a significant reduction in tumor weight, with a tumor growth inhibition rate of 74.0% (P < 0.01), However, TRI-03 had no significant inhibitory effect in the Atg7-shRNA group (P = 0.66) (Figures 6B,C).